Landscape Capital Management’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-944
Closed -$67K 518
2017
Q2
$67K Hold
944
0.01% 310
2017
Q1
$52K Buy
+944
New +$42.2K 0.01% 493
2016
Q3
Sell
-1,066
Closed -$43K 485
2016
Q2
$43K Sell
1,066
-3,553
-77% -$165K 0.01% 525
2016
Q1
$215K Buy
4,619
+3,119
+208% +$132K 0.03% 503
2015
Q4
$63K Sell
1,500
-393
-21% -$16.5K 0.01% 951
2015
Q3
$74K Sell
1,893
-127
-6% -$5.93K 0.01% 616
2015
Q2
$102K Buy
2,020
+503
+33% +$25.8K 0.02% 668
2015
Q1
$88K Buy
+1,517
New +$63.2K 0.02% 493

Other funds holding FBIO

Landscape Capital Management's FBIO Position: Q3 2017 in Review

Landscape Capital Management sold out of Fortress Biotech (FBIO) in Q3 2017, closing a stake of 944 shares — an estimated $67K sold.

Landscape Capital Management first reported a position in FBIO in Q1 2015 and held it in 8 quarters. The position peaked at $215K in Q1 2016. 58 funds tracked by Wall St. Rank hold FBIO as of Q3 2017.

  • Landscape Capital Management reported no remaining Fortress Biotech position as of Q3 2017 after selling out during the quarter.
  • Landscape Capital Management sold 944 Fortress Biotech shares in Q3 2017, an estimated $67K.
  • Landscape Capital Management first reported a position in Fortress Biotech in Q1 2015 and held it in 8 quarters.
  • Landscape Capital Management's Fortress Biotech position peaked at $215K in Q1 2016.
  • 58 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2017.

Based on Landscape Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.